0001209191-20-003457.txt : 20200115 0001209191-20-003457.hdr.sgml : 20200115 20200115160848 ACCESSION NUMBER: 0001209191-20-003457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200113 FILED AS OF DATE: 20200115 DATE AS OF CHANGE: 20200115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parini Michael CENTRAL INDEX KEY: 0001661567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20528393 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-13 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001661567 Parini Michael C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CL&AO Common Stock 2020-01-13 4 M 0 2125 90.29 A 37128 D Common Stock 2020-01-13 4 S 0 300 225.27 D 36828 D Common Stock 2020-01-13 4 S 0 1225 226.42 D 35603 D Common Stock 2020-01-13 4 S 0 300 227.56 D 35303 D Common Stock 2020-01-13 4 S 0 300 228.99 D 35003 D Stock Option (Right to Buy) 90.29 2020-01-13 4 M 0 2125 0.00 D 2026-07-11 Common Stock 2125 4250 D Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $225.27 (range $224.75 to $225.57). Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $226.42 (range $226.06 to $227.01). Open market sales reported on this line occurred at a weighted average price of $227.56 (range $227.53 to $227.62). Open market sales reported on this line occurred at a weighted average price of $228.99 (range $228.79 to $229.27). The option vests in 16 quarterly installments from 07/12/2016. /s/ Omar White, Attorney-in-Fact 2020-01-15